Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
17.47
-0.86 (-4.69%)
At close: Jan 15, 2026, 4:00 PM EST
17.65
+0.18 (1.03%)
Pre-market: Jan 16, 2026, 7:28 AM EST
Schrödinger Market Cap
Schrödinger has a market cap or net worth of $1.29 billion as of January 16, 2026. Its market cap has decreased by -6.15% in one year.
Market Cap
1.29B
Enterprise Value
1.01B
1-Year Change
-6.15%
Ranking
Category
Stock Price
$17.47
Market Cap Chart
Since February 6, 2020, Schrödinger's market cap has decreased from $1.76B to $1.29B, a decrease of -26.87%. That is a compound annual growth rate of -5.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 1.29B | -2.29% |
| Dec 31, 2025 | 1.32B | -6.28% |
| Dec 31, 2024 | 1.41B | -45.50% |
| Dec 29, 2023 | 2.58B | 93.68% |
| Dec 30, 2022 | 1.33B | -46.08% |
| Dec 31, 2021 | 2.47B | -55.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |